|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Biotech stocks Vanda and Innoviva are both near buy points, showing some technical strength, despite the stock market correction.
Moody's Japan K.K. has affirmed TDK Corporation's (TDK) A3 issuer rating. "We expect TDK's leverage will return to lower levels within the year as the company pays down debt with proceeds from an impending asset sale," says Takashi Akimoto, a Moody's Assistant Vice President and Analyst. TDK is in an agreement with QUALCOMM Incorporated (Qualcomm, A2 negative) to sell its smartphone components joint venture to Qualcomm in two parts.